From June 1 to 5, 2026, The United Laboratories (Inner Mongolia) Co., Ltd. successfully completed two top‑tier global pharmaceutical regulatory on‑site inspections simultaneously: the EU‑GMP re‑inspection by Germany's BJV and the unannounced inspection by the U.S. FDA. The company's mature and comprehensive international quality control system was recognized by both authoritative agencies, demonstrating the hardcore quality strength and team cohesion of TUL Taking this inspection as a new starting point, TUL will adhere to global pharmaceutical compliance standards, deepen its international layout, and build a strong Chinese pharmaceutical international brand with high‑quality API products.